miRecule’s Drug Development Process

miRecule has developed a novel screening platform to identify the best miR mimic targets for particular cancers. Once lead targets have been identified, miRecule utilizes its expertise in nucleic acid chemistry to chemically modify these compounds for improved stability and therapeutic potency.

______________________________________________________________________________________________________